Author Archives: admin


UCI stem cell scientist wins coveted NIH New Innovator Award

PUBLIC RELEASE DATE:

6-Oct-2014

Contact: Tom Vasich tmvasich@uci.edu 949-824-6455 University of California - Irvine @UCIrvine

Irvine, Calif., Oct. 6, 2014 UC Irvine scientist Weian Zhao will receive a prestigious National Institutes of Health Director's New Innovator Award to further his efforts to create stem cell-based detection methods and treatments for cancer.

It's part of the highly selective High Risk-High Reward Research Award Program and supports projects by early-career biomedical researchers with the potential to transform scientific fields and accelerate the translation of research into new ways to improve human health.

Zhao, an assistant professor of pharmaceutical sciences, will get $1.5 million over five years. He's among 50 investigators selected for the 2014 award.

His project is to engineer smart stem cell systems to effectively detect and treat the spread of cancer in the body. Cancer metastases are responsible for more than 90 percent of cancer deaths; however, few current therapies directly target metastatic cancer.

Zhao's goal is to have stem cell messengers selectively migrate to cancer sites to deliver tumor-fighting drugs or probes for contrast-enhanced medical imaging. This could, potentially, enable the identification of cancer micro-metastases at their early stages and increase the effectiveness of chemotherapeutic treatments for metastatic cancer while mitigating the symptoms associated with systemic chemotherapy.

"It's a great honor to receive this prestigious award," he said. "In particular, its high-risk-high-reward spirit gives us the freedom to pursue out-of-the-box approaches to the biggest challenge in cancer."

Zhao is a member of the Sue & Bill Gross Stem Cell Research Center and the Chao Family Comprehensive Cancer Center at UCI, with a joint appointment in the Department of Biomedical Engineering. He has received numerous awards and was named to MIT Technology Review's 2012 TR35 list of the world's top 35 innovators under the age of 35.

Read the original:
UCI stem cell scientist wins coveted NIH New Innovator Award

Stem Cells, Malaria, and the Genetics of Drug Response Highlighted at Penn's 9th Annual Translational Medicine Symposium

Contact Information

Available for logged-in reporters only

Newswise PHILADELPHIA The University of Pennsylvanias Institute for Translational Medicine and Therapeutics 9th Annual International Symposium (ITMAT), Progress in Translational Science: Emerging Therapeutic Modalities, will be held on October 13-14. The symposium will feature outstanding speakers from the United States and abroad to address topics at the core of translational science. Speakers will include experts researching advances in stem cell biology, single cell metabolomics, and infectious diseases.

Date: Monday and Tuesday, October 13 - 14, 2013, starting at 8:30 am.

Location: Smilow Center for Translational Research, Rubenstein Auditorium and Lobby, 3400 Civic Center Blvd, Philadelphia, PA 19104

Additional details:

The symposium will feature presentations in six major areas:

Challenges and Opportunities in Translational Research Stem Cell Therapeutics Movement in Malaria Focus on the Single Cell Variability in Drug Response Translational Immunology

Garret A. FitzGerald, MD, Director of ITMAT, will host the event. Speakers and talks include:

Kenneth S. Zaret, PhD, Joseph Leidy Professor of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania Discovering networks and diagnostics for pancreatic cancer progression

See the rest here:
Stem Cells, Malaria, and the Genetics of Drug Response Highlighted at Penn's 9th Annual Translational Medicine Symposium

BioEden the specialist tooth stem cell bank plan to shake up public perception as Stem Cell Awareness week takes hold.

(PRWEB UK) 7 October 2014

Stem cell treatments take place in countries all around the world every day. Thousands of lives have already been saved, and advancements in this area of medicine means that future healthcare treatments look set to further prolong and improve life.

But specialist stem cell bank BioEden warn that there is a risk of thinking of stem cell therapy in terms of the future alone. 'The need to have a stem cell match is vital', says Group CEO Mr Tony Veverka. 'Without access to a stem cell match, the work of stem cell scientists could be at risk. That is the reason why BioEden was set up, to ensure that anyone could bank and have access to their own stem cells. We also wanted to ensure that the brilliant work being carried out by stem cell scientists and medical professionals could continue unhindered'.

BioEden's services are being promoted by Health Care Professionals including specialist insurance intermediaries, and dentists. This week to highlight Stem Cell Awareness week, members of their specialist teams will be on the road visiting dentists, schools and healthcare insurance companies.

'Let's make everyone aware of the opportunities they have to store their own cells during stem cell awareness week. Perhaps we need to re name it Stem Cell Self-Awareness week'.

For more information visit http://www.bioeden.com

View post:
BioEden the specialist tooth stem cell bank plan to shake up public perception as Stem Cell Awareness week takes hold.

SCI 1 1 Xiaoyanzi-(Female,36-year-old)-C4-C5 Spinal Cord Injury- Before stem cell treatment – Video


SCI 1 1 Xiaoyanzi-(Female,36-year-old)-C4-C5 Spinal Cord Injury- Before stem cell treatment
Xiaoyanzi is a Chinese 36 years old female patient suffering from spinal cord injury. She underwent a car crash in June, 2014, then was diagnosed as C4-C5 vertebral bodies fracture with relevant...

By: Stem Cells

See the rest here:
SCI 1 1 Xiaoyanzi-(Female,36-year-old)-C4-C5 Spinal Cord Injury- Before stem cell treatment - Video

SCI1 2 Xiaoyanzi-(Male,1-year-old)-C4-C5 Spinal Cord Injury-After the 1st round stem cell treatment – Video


SCI1 2 Xiaoyanzi-(Male,1-year-old)-C4-C5 Spinal Cord Injury-After the 1st round stem cell treatment
Xiaoyanzi is a Chinese 36 years old female patient suffering from spinal cord injury. She underwent a car crash in June, 2014, then was diagnosed as C4-C5 vertebral bodies fracture with relevant...

By: Stem Cells

Go here to see the original:
SCI1 2 Xiaoyanzi-(Male,1-year-old)-C4-C5 Spinal Cord Injury-After the 1st round stem cell treatment - Video

1 3 Xiaoyanzi-(Male,1-year-old)-C4-C5 Spinal Cord Injury-Before the 2nd round stem cell treatmentnt – Video


1 3 Xiaoyanzi-(Male,1-year-old)-C4-C5 Spinal Cord Injury-Before the 2nd round stem cell treatmentnt
Xiaoyanzi is a Chinese 36 years old female patient suffering from spinal cord injury. She underwent a car crash in June, 2014, then was diagnosed as C4-C5 vertebral bodies fracture with relevant...

By: Stem Cells

Original post:
1 3 Xiaoyanzi-(Male,1-year-old)-C4-C5 Spinal Cord Injury-Before the 2nd round stem cell treatmentnt - Video

Family of Margot Martini launch new stem cell and bone marrow appeal

VIEW GALLERY

The family of brave toddler Margot Martini launched a new bone marrow donor appeal this morning exactly a year after she was diagnosed with leukaemia.

Her relatives said the first Team Margot Stem Cell and Bone Marrow Awareness Day would be held in another 12 months, on Wednesday October 7, 2015.

The two-year-old underwent a bone marrow transplant in February after her dad, Yaser, from Essington, and mum Vicki launched a desperate appeal for help.

Margot Martini with mum Vicky

But she relapsed and her parents decided to end her treatment after being told her chances of survival were less than one per cent.

The awareness day is designed to promote awareness around the need for more potential stem cell donors to join the UK and worldwide registries.

Her family said they hoped mixed race people would sign up to plug a gaping hole on the lists.

Just sixty per cent of the 37,000 patients needing a stem cell donor worldwide receives a perfect match.

But that figure plunges to barely 20 per cent for those from black, Asian or ethnic minority communities.

Read the original post:
Family of Margot Martini launch new stem cell and bone marrow appeal